Polmann L, Schliemann C, Sgonina LM, Heptner B, Eisfeld C, Marx J, Mikesch J-H, Reicherts C, Bleckmann A, Lenz G, Stelljes M, Wethmar K. Measurable residual disease-negative remission of BRAF-V600Emutated acute myeloid leukemia with dabrafenib and trametinib. Haematologica; https://doi.org/10.3324/haematol.2026.301553 [Early view].